Role: Working with many different disease models and preclinical imaging. Assistance in planning and practical execution of in vivo experiments and preclinical PET imaging studies.

Role: Scheduling and technical operation of PET scanners used in the groups preclinical trials and updating the imaging/trial database.

Project: Molecular imaging of caldiovascular disease in type-2 diabetes: evaluation of experimental models and their responses to treatment.

Funding: Drug Research Doctoral Programme, Turku University Foundation.

Project: Molecular imaging of cardiac inflammation using new PET tracers in experimental models.

Funding: Doctoral Program of Clinical Research, Finnish Foundation for Cardiovascular Research 

Project: Determining the effects of diet, microbiological status and microbiota on the metabolic phenotype of ApoE-/- mice as a model for drug development .

Project: Development of Positron Emission Tomography (PET) Imaging Agent Targeting Macrophage Mannose Receptor (MMR) in Cardiovascular Disease and Cancer.

Funding: Turku University Foundation.

Project: Molecular imaging in myocardial infarction.

Radiopharmaceutical 18F-PEG-Folate: Radiosynthesis and evaluation of in vitro binding and in vivo imaging of inflammation.

Project: Folate receptor beta as an imaging target in myocardial infarction.

Project : Detection of Intestinal Inflammation by [68Ga]Ga-DOTA-Siglec-9 PET Imaging in Mouse Models of IBD and Patients with Crohn’s disease.

Project : Molecular imaging of inflammation in bowel disease using new PET tracers in experimental models.

Project: Effect of exercise on immune cell responses during cancer treatment: CD8+ T cells and adhesion molecule VAP-1 of special interest.

 Emerging radiopharmaceuticals for PET-imaging gliomas. A multi-: radiopharmaceutical, camera, modality, model, and modelling assessment